Qianlan Yao

复旦大学

H指数:21

被引数:1,223

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrative Multi-Omics Analysis Reveals a Mitochondrial–Immune Axis Associated With Neoadjuvant Chemotherapy Response in High-Grade Serous Ovarian Cancer

整合多组学分析揭示高分级浆液性卵巢癌新辅助化疗反应相关的线粒体-免疫轴

Advanced Science

IF14.1

2026-07-280

OAAI

Dedifferentiated/Undifferentiated Endometrial Carcinoma:SWI/SNF-deficiency and molecular heterogeneity indicating novel prognostic stratification in a single-center study of 71 cases

去分化/未分化子宫内膜癌：SWI/SNF功能缺失与分子异质性提示单中心71例研究中的新型预后分层

Human Pathology

IF2.6

2026-05-190

PRE

Clinicopathological and molecular characteristics of rare ovarian sex cord stromal tumors with BAP1 mutation

罕见卵巢性索间质肿瘤的 clinicopathological 和分子特征及 BAP1 突变

Virchows Archiv

IF3.1

2026-04-100

PRE

YTHDF3 promotes breast cancer osteolytic bone metastasis by enhancing the translation of ZEB1 and SMAD5

YTHDF3通过增强ZEB1和SMAD5的翻译来促进乳腺癌溶骨性骨转移。

Oncogenesis

IF6.4

2025-11-170

OAAI

CDKN2A Alternations in Non-Small Cell Lung Cancer: An Evaluation Using Next-generation Sequencing

非小细胞肺癌中CDKN2A基因变异：基于下一代测序技术的评估

pathology research and practice

IF0

2025-08-140

PRE

BAP1 Tumor Predisposition Syndrome: ovarian sex cord-stromal tumors

LABORATORY INVESTIGATION

IF4.2

2025-03-010

PRE

PLAG1-Rearranged Sarcomas: A Study of 10 Cases Showing Distinct Histological Features beyond Myxoid Morphology

LABORATORY INVESTIGATION

IF4.2

2025-03-010

PRE

An accurate DNA and RNA based targeted sequencing assay for clinical detection of gene fusions in solid tumors

SCIENTIFIC REPORTS

IF3.9

2025-02-280

OAAI

Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-Center Retrospective Cohort Study in a Chinese Population

THYROID

IF6.7

2024-10-011

PRE

Approaches for Lynch syndrome screening and characteristics of subtypes with mismatch repair deficiency in patients with colorectal carcinoma

结直肠癌患者Lynch综合征筛查方法及错配修复缺陷亚型特征

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2024-08-070

YTHDF1 promotes the osteolytic bone metastasis of breast cancer via inducing EZH2 and CDH11 translation

YTHDF1通过诱导EZH2和CDH11翻译促进乳腺癌溶骨性骨转移

CANCER LETTERS

IF10.1

2024-08-013

PRE

Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort

子宫内膜癌FIGO 2023分期系统在中国队列中的临床应用

BMC CANCER

IF3.4

2024-07-184

OAAI

Comprehensive analysis of next generation sequencing and ARMS-PCR for detecting EGFR exon 20 insertion (ex20ins) mutations in Chinese non-small cell lung cancer patients

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2024-05-010

OAAI

A custom next-generation sequencing panel for 1p/19q codeletion and mutational analysis in gliomas

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

IF3

2024-02-260

PRE

NOTCH1 Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung Cancer

IMMUNOTARGETS AND THERAPY

IF4.4

2023-12-012

OAAI

The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer

CANCER LETTERS

IF10.1

2023-03-0118

PRE

GLI1-rearranged mesenchymal tumor in the ovary

HISTOPATHOLOGY

IF4.1

2022-09-079

PRE

lncRNA pair as candidate diagnostic signature for colorectal cancer based on the within-sample relative expression levels

FRONTIERS IN ONCOLOGY

IF3.3

2022-08-171

OAAI

Uterine tumours with myogenic differentiation harbouring SRF::RELA fusions

HISTOPATHOLOGY

IF4.1

2022-08-034

PRE

Diagnostic performance of next-generation sequencing and genetic profiling in thyroid nodules from a single center in China

EUROPEAN THYROID JOURNAL

IF4.3

2022-06-0112

OAAI

Qianlan Yao

个人简介

教育背景

工作经历

荣誉奖项

研究方向